Search
Desmethylprodine
go.drugbank.com/drugs/DB01478ExperimentalIllicitIt is known to be a designer drug, synthesized in 1977, for the purpose of recreational use. Illicit manufacturing has occurred.
2-hydroxy-7-methoxy-5-methyl-naphthalene-1-carboxylic acid meso-2,5-dihydroxy-cyclopent-3-enyl ester
go.drugbank.com/drugs/DB08261ExperimentalThis compound belongs to the naphthalenecarboxylic acids and derivatives. These are compounds containing a napthalene moiety with a ring carbon which bears a carboxylic acid group or a derivative.
GSK-945237
go.drugbank.com/drugs/DB15345InvestigationalGSK-945237 is under investigation in clinical trial NCT01039610 (A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose
TAK-751S
go.drugbank.com/drugs/DB06432InvestigationalTAK-751S is a synthetic analog of Shiga toxin (Stx) receptor, Gb3, produced by enterohemorrhagic _Escherichia coli_.[A260296]
Sparsomycin
go.drugbank.com/drugs/DB04222ExperimentalAn antitumor antibiotic produced by Streptomyces sparsogenes. It inhibits protein synthesis in 70S and 80S ribosomal systems. [PubChem]
NM3086
go.drugbank.com/drugs/DB17719ExperimentalNM3086 is a recombinant, humanized, aglycosylated, IgG1-kappa anti-properdin monoclonal antibody being developed by Novelmed Therapeutics Inc.[L46193]
Synonyms: NM 3086, NM-3086Canertinib
go.drugbank.com/drugs/DB05424InvestigationalCanertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.
Afimoxifene
go.drugbank.com/drugs/DB04468InvestigationalIt is being developed by Ascent Therapeutics.
Adelmidrol
go.drugbank.com/drugs/DB16083InvestigationalPlacebo for Gynecologic Oncology Patients Affected by Vaginitis).
JNJ-17216498
go.drugbank.com/drugs/DB17087InvestigationalJNJ-17216498 is a histamine receptor H3 antagonist developed by Johnson and Johnson for the treatment of narcolepsy.[A253997]